TRAIL in the Airways

Vitamins and Hormones

Volumn 67, Issue , 2004, Pages 149-167

  Robertson, Noreen M ^a   Rosemiller, Mary ^a   Lindemeyer, Rochelle G ^c   Steplewski, Andrzej ^a   Zangrilli, James G ^d   Litwack, Gerald ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Toluca Lake   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; GLUCOCORTICOID; MEMBRANE PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ASTHMA; BLOOD VESSEL; EPITHELIUM; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PHYSIOLOGY; PROMOTER REGION; RESPIRATORY SYSTEM; REVIEW; SMOOTH MUSCLE;

APOPTOSIS REGULATORY PROTEINS; ASTHMA; BLOOD VESSELS; EPITHELIUM; FIBROBLASTS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH; PROMOTER REGIONS (GENETICS); RESPIRATORY SYSTEM; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042784480     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(04)67009-9     Document Type: Article

References (83)

1. T Adachi S Motojima A Hirata T Fukuda N Kihara S Makino Detection of transforming growth factor-beta in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay Clin. Exp. Allergy 26 1996 557 562
2. T Adachi S Motojima A Hirata T Fukuda S Makino Eosinophil-viability enhancing activity in sputum from patients with bronchial asthma. Contributions of interleukin-5 and granulocyte⧸macrophage colony-stimulating factor Am. J. Respir. Crit. Care. Med. 151 1995 618 623
3. I.M Adcock C.R Brown H Shirasaki P.J Barnes Effects of dexamethasone on cytokine and phorbol ester stimulated c-Fos and c-Jun DNA binding and gene expression in human lung Eur. Respir. J. 7 1994 2117 2123
4. A Almasan A Ashkenazi Apo2L⧸TRAIL: Apoptosis signaling, biology, and potential for cancer therapy Cytokine Growth Factor Rev. 14 2003 337 348
5. A.J Ammit R.K Hoffman Y Amrani A.L Lazaar D.W Hay T.J Torphy R.B Penn R.A Panettieri Jr. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate Am. J. Respir. Cell. Mol. Biol. 23 2000 794 802
6. A.J Ammit A.L Lazaar C Irani G.M O'Neill N.D Gordon Y Amrani R.B Penn R.A Panettieri Jr. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: Modulation by glucocorticoids and beta-agonists Am. J. Respir. Cell. Mol. Biol. 26 2002 465 474
7. E.A Ariazi Y Satomi M.J Ellis J.D Haag W Shi C.A Sattler M.N Gould Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol [in process citation] Cancer Res. 59 1999 1917 1928
8. A Ashkenazi V.M Dixit Death receptors: Signaling and modulation Science 281 1998 1305 1308
9. A Ashkenazi V.M Dixit Apoptosis control by death and decoy receptors Curr. Opin. Cell. Biol. 11 1999 255 260
10. P Barnes Cytokines as mediators of chronic asthma Am. J. Respir. Crit. Care Med. 150 1994 S42 S49
11. P Bogdanowicz J.P Pujol Glycosylphosphatidylinositol (GPI) hydrolysis by transforming growth factor-beta1 (TGF-beta1) as a potential early step in the inhibition of epithelial cell proliferation Mol. Cell. Biochem. 208 2000 143 150
12. J Bousquet P Chanez A.M Vignola J.-Y Lacoste F.B Michel Eosinophil inflammation in asthma Am. Rev. Crit. Care Med. 150 1994 S33 S38
13. D.H Broide M Lotz A.J Cuomo D.A Coburn E.C Federman S.I Wasserman Cytokines in symptomatic asthma airways J. Allergy Clin. Immunol. 89 1992 958 967
14. F Bucchieri S.M Puddicombe J.L Lordan A Richter D Buchanan S.J Wilson J Ward G Zummo P.H Howarth R Djukanovic S.T Holgate D.E Davies Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis Am. J. Respir. Cell. Mol. Biol. 27 2002 179 185
15. N.G Carroll C Cooke A.L James Bronchial blood vessel dimensions in asthma Am. J. Respir. Crit. Care Med. 155 1997 689 695
16. K.F Chung Airway smooth muscle cells: Contributing to and regulating airway mucosal inflammation? Eur. Respir. J. 15 2000 961 968
17. R.K Coker G.J Laurent S Shahzeidi P.A Lympany R.M du Bois P.K Jeffery R.J McAnulty Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis Am. J. Pathol. 150 1997 981 991
18. A.M Colavita A.T Hastie A.J Musani R.M Pascual A.J Reinach H.T Lustine S.A Galati J.G Zangrilli J.E Fish S.P Peters Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects J. Allergy Clin. Immunol. 106 2000 880 886
19. I Daigle H.U Simon Alternative functions for TRAIL receptors in eosinophils and neutrophils Swiss Med. Wkly. 131 2001 231 237
20. M.A Degli-Esposito W.C Dougall P.J Smolak J.Y Waugh C.A Smith R.G Goodwin The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet remains an incomplete death domain Immunity 7 1997 813 820
21. M.A Degli-Esposito P.J Smolak H Walczak J.Y Waugh C.P Huang R.F DuBose R.G Goodwin C.A Smith Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family J. Exp. Med. 186 1997 1165 1170
22. M Degli-Esposti To die or not to die—the quest of the TRAIL receptors J. Leukoc. Biol. 65 1999 535 542
23. M.S Dunill The pathology of asthma, with special reference to changes in the bronchial mucosa J. Clin. Pathol. 13 1960 27 31
24. D.R Edwards G Murphy J.J Reynolds S.E Whitham A.J Docherty P Angel J.K Heath Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor EMBO J. 6 1987 899 904
25. O Eickelberg E Kohler F Reichenberger S Bertschin T Woodtli P Erne A.P Perruchoud M Roth Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3 Am. J. Physiol. 276 1999 L814 L824
26. N.A Fanger C.R Maliszewski K Schooley T.S Griffith Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) J. Exp. Med. 190 1999 1155 1164
27. A Fine R.H Goldstein The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts J. Biol. Chem. 262 1987 3897 3902
28. M.A Giembycz M.A Lindsay Pharmacology of the eosinophil Pharmacol. Rev. 51 1999 213 340
29. G.J Gleich Mechanisms of eosinophil-associated inflammation J. Allergy Clin. Immunol. 105 2000 651 663
30. B Gong A Almasan Genomic organization and transcriptional regulation of human Apo2⧸TRAIL gene Biochem. Biophys. Res. Commun. 278 2000 747 752
31. T.S Griffith S.R Wiley M.Z Kubin L.M Sedger C.R Maliszewski N.A Fanger Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL J. Exp. Med. 189 1999 1343 1354
32. H Hakonarson E Halapi R Whelan J Gulcher K Stefansson M.M Grunstein Association between IL-1beta⧸TNF-alpha-induced glucocorticoid-sensitive changes in multiple gene expression and altered responsiveness in airway smooth muscle Am. J. Respir. Cell. Mol. Biol. 25 2001 761 771
33. M.P Hallsworth L.M Moir D Lai S.J Hirst Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle Am. J. Respir. Crit. Care Med. 164 2001 688 697
34. M.P Hallsworth C.P Soh C.H Twort T.H Lee S.J Hirst Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival Am. J. Respir. Cell. Mol. Biol. 19 1998 910 919
35. K Ito S Lim G Caramori B Cosio K.F Chung I.M Adcock P.J Barnes A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression Proc. Natl. Acad. Sci. USA 99 2002 8921 8926
36. I Jeremias K.M Debatin TRAIL induces apoptosis and activation of NFκB Eur. Cytokine Netw. 9 1998 687 688
37. N Kayagaki N Yamaguchi M Nakayama H Eto K Okumura H Yagita Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs J. Exp. Med. 189 1999 1451 1460
38. N Kayagaki N Yamaguchi M Nakayama A Kawasaki H Akiba K Okumura H Yagita Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity J. Immunol. 162 1999 2639 2647
39. M Krupsky A Fine P.P Kuang J.L Berk R.H Goldstein Regulation of type I collagen production by insulin and transforming growth factor-beta in human lung fibroblasts Connect Tissue Res. 34 1996 53 62
40. U Kucich J.C Rosenbloom D.J Herrick W.R Abrams A.D Hamilton S.M Sebti J Rosenbloom Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts Arch. Biochem. Biophys. 395 2001 103 112
41. N.M Kumar N.H Rabadi L.S Sigurdson H.J Schunemann J.S Lwebuga-Mukasa Induction of interleukin-1 and interleukin-8 mRNAs and proteins by TGF beta 1 in rat lung alveolar epithelial cells J. Cell. Physiol. 169 1996 186 199
42. M Laiho O Saksela P.A Andreasen J Keski-Oja Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta J. Cell. Biol. 103 1986 2403 2410
43. F Li G Ambrosini E.Y Chu J Plescia S Tognin P.C Marchisio D.C Altieri Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
44. F.F Lopez D.J Williamson J.R Gamble C.J Begley J.M Harlan S.J Klebanoff A Waltersdorf S Wong S.C Clark M.A Vadas Recombinant granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival J. Clin. Invest. 78 1986 1220 1228
45. N.W Lukacs S.H Oliveira C.M Hogaboam Chemokines and asthma: Redundancy of function or a coordinated effort? J. Clin. Invest. 104 1999 995 999
46. T Masui L.M Wakefield J.F Lechner M.A LaVeck M.B Sporn C.C Harris Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells Proc. Natl. Acad. Sci. USA 83 1986 2438 2442
47. S McKay H.S Sharma Autocrine regulation of asthmatic airway inflammation: Role of airway smooth muscle Respir. Res. 3 2002 11
48. E.M Minshall D.Y Leung R.J Martin Y.L Song I Cameron P Ernst Q Hamid Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma Am. J. Resp. Cell. Mol. Biol. 17 1997 326 333
49. S Motojima T Adachi K Manaka M Arima T Fukuda S Makino Eosinophil peroxidase stimulates the release of granulocyte-macrophage colony-stimulating factor from bronchial epithelial cells J. Allergy Clin. Immunol. 98 1996 S216 S223
50. B Muller Cytokine imbalance in non-immunological chronic disease Cytokine 18 2002 334 339
51. G Pan K O'Rouke A.M Chinnaiyan R Gentz R Ebner J Ni V.M Dixit The receptor for the cytotoxic ligand TRAIL Nature 276 1997 111 113
52. R.M Pitti S.A Marsters S Ruppert C.J Donahue A Moore A Ashkenazi Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J. Biol. Chem. 271 1996 12687 12690
53. R.N Poston P Chanez J.Y Lacoste T Litchfield T.H Lee J Bousquet Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi Am. Rev. Resp. Dis. 145 1995 918 921
54. D.A Ricupero D.C Rishikof P.P Kuang C.F Poliks R.H Goldstein Regulation of connective tissue growth factor expression by prostaglandin E(2) Am. J. Physiol. 277 1999 L1165 1171
55. N.M Robertson J.G Zangrilli A Steplewski A Hastie R.G Lindemeyer M.A Planeta M.K Smith N Innocent A Musani R Pascual S Peters G Litwack Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: Evidence for a role of TRAIL in eosinophil survival J. Immunol. 169 2002 5986 5996
56. M.E Rothenberg W.F Owen D.S Silberstein J Woods R.J Soberman K.F Austen R.L Stevens Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to GM-CSF J. Clin. Invest. 78 1988 1220 1228
57. M.E Rothenberg J Peterson R.L Stevens D.S Silberstein D.T McKenzie K.F Austen W.F Owen IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced vibility, accelerated hypodense and sustained antibody-dependent cytotoxicity J. of Immunol. 143 1989 3211 3216
58. S.M Santini C Lapenta M Logozzi S Parlato M Spada T Di Pucchio F Belardelli Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice J. Exp. Med. 191 2000 1777 1788
59. K Sato S Hida H Takayanagi T Yokochi N Kayagaki K Takeda H Yagita K Okumura N Tanaka T Taniguchi K Ogasawara Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha⧸beta Eur. J. Immunol. 31 2001 3138 3146
60. M Sato H Takizawa T Kohyama T Ohtoshi S Takafuji S Kawasaki S Tohma A Ishii S Shoji K Ito Eosinophil adhesion to human bronchial epithelial cells: Regulation by cytokines Int. Arch. Allergy Immunol. 113 1997 203 205
61. P Schneider M Thome K Burns J.L Bodmer K Hofmann T Kataoka N Holler J Tschopp TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB Immunity 7 1997 831 836
62. P Secchiero A Gonelli E Carnevale D Milani A Pandolfi D Zella G Zauli TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways Circulation 107 2003 2250 2256
63. M Seminarino G.J Gleich The role of eosinophils in the pathogenesis of asthma Curr. Opin. Immunol. 6 1994 860 864
64. J.R Shaver J Zangrilli S.K Cho R.A Cirelli M Pollice A.T Hastie J.E Fish S.P Peters Kinetics of the development and recovery of the lung from IgE-mediated inflammation: Dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines Am. J. Respir. Crit. Care Med. 155 1997 442 448
65. J.P Sheridan S.A Marsters R.M Pitti A Gurney M Skubatch D Baldwin L Ramakrishnan C.L Gray K Baker W.I Wood A.D Goddard P Godowski A Ashkenazi Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors [see comments] Science 277 1997 18 21
66. M.J Smyth E Cretney K Takeda R.H Wiltrout L.M Sedger N Kayagaki H Yagita K Okumura Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis J. Exp. Med. 193 2001 661 670
67. K Takeda Y Hayakawa M.I Smyth N Kayagaki N Yamaguchi S Kakuta Y Iwakura H Yagita K Okumura Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells Nat. Med. 7 2001 94 100
68. R Temple E Allen J Fordham S Phipps H.C Schneider K Lindauer I Hayes J Lockey K Pollock R Jupp Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes Am. J. Respir. Cell. Mol. Biol. 25 2001 425 433
69. H Walczak M.A Degliesposti R.S Johnson P.J Smolak J.Y Waugh N Boiani M.S Timour M.J Gerhart K.A Schooley C.A Smith R.G Goodwin C.T Rauch Trail-R2–a novel apoptosis-mediating receptor for TRAIL EMBO J. 16 1997 5386 5397
70. Q Wang Y Ji X Wang B.M Evers Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene Biochem. Biophys. Res. Commun. 276 2000 466 471
71. Q Wang J Yanshan X Wang B.M Evers Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene Biochem. Biophys. Res. Commun. 264 2000 813 819
72. Q Wang X Wang A Hernandez M.R Hellmich Z Gatalica B.M Evers Regulation of trail expression by the PI3-KINASE⧸Akt⧸GSK-3 pathway in human colon cancer cells J. Biol. Chem. 24 2002 24
73. Y Wang S Yi Y.C Tay X Feng L Kairaitis D.C Harris Transfection of tubule cells with Fas ligand causes leukocyte apoptosis Kidney Int. 61 2002 1303 1311
74. A.J Wardlaw C.E Brightling R Green G Woltmann P Bradding I.D Pavord New insights into the relationship between airway inflammation and asthma Clin. Sci. (Lond.) 103 2002 201 211
75. S.E Wenzel J.B Trudeau S Barnes X Zhou M Cundall J.Y Westcott K McCord H.W Chu TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts J. Immunol. 169 2002 4613 4619
76. S.R Wiley K Schooley P.J Smolak W.S Din C.P Huang J.K Nicholl G.R Sutherland T.D Smith C Rauch C.A Smith Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
77. J.W Wilson T.L Bamford Assessing the evidence for remodelling of the airway in asthma Pulm. Pharmacol. Ther. 14 2001 229 247
78. E.C Winchester I.Y Millwood L Rand M.A Penny A.M Kessling Association of the TNF-alpha-308 (G→A) polymorphism with self-reported history of childhood asthma Hum. Genet. 107 2000 591 596
79. K Yanagisawa H Osada A Masuda M Kondo T Saito Y Yatabe K Takagi T Takahashi Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells Oncogene 17 1998 1743 1747
80. Y Yu S Liu W Wang W Song M Zhang W Zhang Z Qin X Cao Involvement of tumour necrosis factor-alpha-related apoptosis-inducing ligand in enhanced cytotoxicity of lipopolysaccharide-stimulated dendritic cells to activated T cells Immunology 106 2002 308 315
81. V.V Yurovsky Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts Am. J. Respir. Cell. Mol. Biol. 28 2003 225 231
82. L Zamai M Ahmad I.M Bennett L Azzoni E.S Alnemri B Perussia Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells J. Exp. Med. 188 1998 2375 2380
83. J.G Zangrilli J.R Shaver R.A Cirelli S.K Cho C.G Garlisi A Falcone F.M Cuss J.E Fish S.P Peters sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response Am. J. Resp. Crit. Care Med. 151 1995 1346 1353